Preferred Name |
tegaserod |
|
Synonyms |
Zelnorm SDZ HTF-919 tegaserod maleate HTF 919 5-methoxyindol-3-carboxaldehyde amino(pentylamino)methylenehydrazone hydrogen maleate Zelmac SDZ HTF 919 |
|
ID |
http://purl.bioontology.org/ontology/MESH/C105050 |
|
altLabel |
Zelnorm SDZ HTF-919 tegaserod maleate HTF 919 5-methoxyindol-3-carboxaldehyde amino(pentylamino)methylenehydrazone hydrogen maleate Zelmac SDZ HTF 919 |
|
cui |
C0966948 C1138594 C0537147 C1137921 |
|
HM |
D007211 |
|
II |
D005765 |
|
Inverse of RB |
458VC51857 E5XNT3RF5A 0 |
|
isa | ||
LT |
TRD |
|
Mapped to | ||
MDA |
19970409 |
|
MeSH Frequency |
309 |
|
MMR |
20160826 |
|
notation |
C105050 |
|
PA |
D017366 |
|
prefLabel |
tegaserod |
|
RR |
145158-71-0 (tegaserod) E5XNT3RF5A |
|
SC |
1 |
|
Scope Statement |
a nonbenzamide 5-hydroxytryptamine(4) agonist; used in treatment of irritable bowel syndrome; marketing suspended 2007 in US due to higher incidence of MI, stroke, and unstable angina; structure given in first source |
|
SRC |
J Pharmacol Exp Ther 1997 Mar;280(3):1270-6 |
|
TERMUI |
T304195 T417752 T507508 T417756 T417755 T417754 T507506 T507505 |
|
TH |
NLM (1997) US NLM (2002) MX NLM (2000) CA FDA SRS (2013) FDA SRS (2017) USAN (19XX) INN (19XX) |
|
tui |
T109 T121 |